Skip to main content

Dermfoot Lectures - Dr Shoham and Dr Joseph

This material is only available to individuals who attended the live event


Objectives: Be aware of the various new categories of antibacterial therapy Understand the epidemiology of resistant bacterial infections Recognize the roles of oral vs. intravenous antibacterial therapy for osteomyelitis


Objectives: Know about currently available antifungal agents Gain an understanding of important antifungal agents currently in development Recognize the growing role of antifungal susceptibility testing


Objectives: Gain an understanding of how to diagnose COVID-19 Recognize ideal timing for treatment with various options Become aware of the various categories of therapy Question and Answer - Open to your most important COVID related questions

About the Speakers:

  • Warren S. Joseph received his B.A. in biology from the University of Pennsylvania, and his Doctor of Podiatric Medicine degree from the William M. Scholl College of Podiatric Medicine in Chicago, Illinois. He completed his residency program in podiatric medicine and surgery in 1984 at St. Joseph’s Hospital in Philadelphia. Following his residency program, Warren did a one-year fellowship in infectious diseases at Hahnemann University School of Medicine. He is board certified by the American Board of Podiatric Orthopedics & Primary Podiatric Medicine.
  • Shmuel Shoham, M.D., has spent most of his nine years at Johns Hopkins diagnosing and caring for patients with infectious diseases, such as pneumonia. But when COVID-19 cases began to soar — with no cure in sight — the associate professor of medicine in the transplant and oncology infectious diseases program felt compelled to act. Building on previous research to treat influenza using antibodies from survivors’ blood, Shoham helped form a consortium of experts to launch clinical trials investigating COVID-19 survivor blood as a treatment.
  • Fees

    Free for Attendees of the Live Meeting

    Intended Audience: Podiatrists

    Refund Policy

    No refunds are available for online courses

    Compliance Statement

    In accordance with the Council on Podiatric Medical Education's Standards and Requirements for Approval of Providers of Continuing Education in Podiatric Medicine, any relevant financial relationships with commercial interests of faculty, planning committee, or any others who have influence over the content of this educational activity must be disclosed to program participants. Neither the planning committee members nor the speaker have any financial relationships to disclose.

    Commercial Interests: No commercial interest provided financial support for this continuing education activity

    For more information contact CMEonline at

    CME Online is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. CME Online has approved this activity for a maximum of 2.14 continuing education contact hour.